Hosted on MSN

Boston Scientific’s global pulsed field ablation trial targets persistent atrial fibrillation growth

Boston Scientific (BSX) announced an update on their ongoing clinical study. Study Overview This global Boston Scientific trial, officially titled “A Global Randomized Trial Comparing Pulsed Field ...
Nasdaq

Boston Scientific receives FDA approval for expanded labeling of FARAPULSE™ Pulsed Field Ablation System

MARLBOROUGH, Mass., July 7, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval to expand the instructions for use (IFU) ...
FierceBiotech

Boston Scientific posts 177% EP growth, pauses Farapulse study in first-line afib

Boston Scientific is keeping the ball rolling in pulsed field ablation, posting 177% electrophysiology growth in the third quarter powered by the launch of its Farapulse system for atrial fibrillation ...
FierceBiotech

In conversation with Boston Scientific's global medical chief, Ken Stein, taking the pulse of pulsed field ablation

Since rolling out its pulsed field ablation system for treating atrial fibrillation earlier this year, Boston Scientific has seen its Farapulse sales grow by leaps and bounds. Last week, during the ...
Nasdaq

Boston Scientific Unveils Cardiac Mapping For FARAPULSE Pulsed Field Ablation System

(RTTNews) - Boston Scientific Corp. (BSX) said it has received U.S. Food and Drug Administration approval for the navigation-enabled FARAWAVE NAV Ablation Catheter for the treatment of paroxysmal ...